DEXCHLORPHENIRAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexchlorpheniramine, and when can generic versions of Dexchlorpheniramine launch?
Dexchlorpheniramine is a drug marketed by Pai Holdings Pharm and Ani Pharms and is included in two NDAs.
The generic ingredient in DEXCHLORPHENIRAMINE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXCHLORPHENIRAMINE?
- What are the global sales for DEXCHLORPHENIRAMINE?
- What is Average Wholesale Price for DEXCHLORPHENIRAMINE?
Summary for DEXCHLORPHENIRAMINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | DEXCHLORPHENIRAMINE at DailyMed |
US Patents and Regulatory Information for DEXCHLORPHENIRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | DEXCHLORPHENIRAMINE MALEATE | dexchlorpheniramine maleate | SYRUP;ORAL | 088251-001 | Mar 23, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ani Pharms | DEXCHLORPHENIRAMINE MALEATE | dexchlorpheniramine maleate | TABLET;ORAL | 088682-001 | Jan 17, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
